Pathogenetic mechanisms and treatment targets in cerebral malaria
- PMID: 37857843
- DOI: 10.1038/s41582-023-00881-4
Pathogenetic mechanisms and treatment targets in cerebral malaria
Erratum in
-
Author Correction: Pathogenetic mechanisms and treatment targets in cerebral malaria.Nat Rev Neurol. 2023 Dec;19(12):787. doi: 10.1038/s41582-023-00899-8. Nat Rev Neurol. 2023. PMID: 37932441 No abstract available.
Abstract
Malaria, the most prevalent mosquito-borne infectious disease worldwide, has accompanied humanity for millennia and remains an important public health issue despite advances in its prevention and treatment. Most infections are asymptomatic, but a small percentage of individuals with a heavy parasite burden develop severe malaria, a group of clinical syndromes attributable to organ dysfunction. Cerebral malaria is an infrequent but life-threatening complication of severe malaria that presents as an acute cerebrovascular encephalopathy characterized by unarousable coma. Despite effective antiparasite drug treatment, 20% of patients with cerebral malaria die from this disease, and many survivors of cerebral malaria have neurocognitive impairment. Thus, an important unmet clinical need is to rapidly identify people with malaria who are at risk of developing cerebral malaria and to develop preventive, adjunctive and neuroprotective treatments for cerebral malaria. This Review describes important advances in the understanding of cerebral malaria over the past two decades and discusses how these mechanistic insights could be translated into new therapies.
© 2023. Springer Nature Limited.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Exploring adjunctive therapies for cerebral malaria.Front Cell Infect Microbiol. 2024 Feb 12;14:1347486. doi: 10.3389/fcimb.2024.1347486. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38410724 Free PMC article. Review.
-
Malaria Related Neurocognitive Deficits and Behavioral Alterations.Front Cell Infect Microbiol. 2022 Feb 22;12:829413. doi: 10.3389/fcimb.2022.829413. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35281436 Free PMC article. Review.
-
Rapid coma resolution with artemether in Malawian children with cerebral malaria.Lancet. 1993 Mar 13;341(8846):661-2. doi: 10.1016/0140-6736(93)90423-e. Lancet. 1993. PMID: 8095573 Clinical Trial.
-
Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria.N Engl J Med. 1992 Nov 19;327(21):1473-7. doi: 10.1056/NEJM199211193272101. N Engl J Med. 1992. PMID: 1406879 Clinical Trial.
Cited by
-
Oral administration of IPI549 protects mice from neuropathology and an overwhelming inflammatory response during experimental cerebral malaria.Int J Parasitol Drugs Drug Resist. 2024 Aug;25:100539. doi: 10.1016/j.ijpddr.2024.100539. Epub 2024 Apr 14. Int J Parasitol Drugs Drug Resist. 2024. PMID: 38621317 Free PMC article.
References
-
- WHO. World Malaria Report 2022 (WHO, 2022).
-
- Reyburn, H. et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. J. Am. Med. Assoc. 293, 1461–1470 (2005). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous